These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 22461703)
1. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. Garg G; Tyler JR; Yang JH; Cutler AJ; Downes K; Pekalski M; Bell GL; Nutland S; Peakman M; Todd JA; Wicker LS; Tree TI J Immunol; 2012 May; 188(9):4644-53. PubMed ID: 22461703 [TBL] [Abstract][Full Text] [Related]
2. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients. Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757 [TBL] [Abstract][Full Text] [Related]
3. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613 [TBL] [Abstract][Full Text] [Related]
4. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells. Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814 [TBL] [Abstract][Full Text] [Related]
5. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients. Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779 [TBL] [Abstract][Full Text] [Related]
6. Decreased regulatory function of CD4 Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447 [TBL] [Abstract][Full Text] [Related]
7. Functional defects in CD4 Guo H; Zheng M; Zhang K; Yang F; Zhang X; Han Q; Chen ZN; Zhu P Sci Rep; 2016 Nov; 6():37559. PubMed ID: 27901054 [TBL] [Abstract][Full Text] [Related]
8. A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling. Goldberg R; Clough JN; Roberts LB; Sanchez J; Kordasti S; Petrov N; Hertweck A; Lorenc A; Jackson I; Tasker S; Appios A; Omer O; Parkes M; Prescott N; Jenner RG; Irving PM; Lord GM J Crohns Colitis; 2021 Dec; 15(12):2054-2065. PubMed ID: 34120187 [TBL] [Abstract][Full Text] [Related]
9. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease. Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251 [TBL] [Abstract][Full Text] [Related]
10. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization. Li CR; Deiro MF; Godebu E; Bradley LM J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722 [TBL] [Abstract][Full Text] [Related]
11. Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes. Yang JH; Cutler AJ; Ferreira RC; Reading JL; Cooper NJ; Wallace C; Clarke P; Smyth DJ; Boyce CS; Gao GJ; Todd JA; Wicker LS; Tree TI Diabetes; 2015 Nov; 64(11):3891-902. PubMed ID: 26224887 [TBL] [Abstract][Full Text] [Related]
12. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway. Wang R; Huang K Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817 [TBL] [Abstract][Full Text] [Related]
13. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. Barreto M; Ferreira RC; Lourenço L; Moraes-Fontes MF; Santos E; Alves M; Carvalho C; Martins B; Andreia R; Viana JF; Vasconcelos C; Mota-Vieira L; Ferreira C; Demengeot J; Vicente AM BMC Immunol; 2009 Jan; 10():5. PubMed ID: 19173720 [TBL] [Abstract][Full Text] [Related]
14. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives. Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701 [TBL] [Abstract][Full Text] [Related]
15. The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. Dendrou CA; Wicker LS J Clin Immunol; 2008 Nov; 28(6):685-96. PubMed ID: 18780166 [TBL] [Abstract][Full Text] [Related]
16. Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. Sebode M; Peiseler M; Franke B; Schwinge D; Schoknecht T; Wortmann F; Quaas A; Petersen BS; Ellinghaus E; Baron U; Olek S; Wiegard C; Weiler-Normann C; Lohse AW; Herkel J; Schramm C J Hepatol; 2014 May; 60(5):1010-6. PubMed ID: 24412607 [TBL] [Abstract][Full Text] [Related]
17. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368 [TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449 [TBL] [Abstract][Full Text] [Related]
19. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Tang Q; Adams JY; Penaranda C; Melli K; Piaggio E; Sgouroudis E; Piccirillo CA; Salomon BL; Bluestone JA Immunity; 2008 May; 28(5):687-97. PubMed ID: 18468463 [TBL] [Abstract][Full Text] [Related]
20. Tuning IL-2 signaling by ADP-ribosylation of CD25. Teege S; Hann A; Miksiewicz M; MacMillan C; Rissiek B; Buck F; Menzel S; Nissen M; Bannas P; Haag F; Boyer O; Seman M; Adriouch S; Koch-Nolte F Sci Rep; 2015 Mar; 5():8959. PubMed ID: 25753532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]